AOL
MAIL
- You might also like:
- AOL Jobs,
- AOL Real Estate
- and More

Ticker

Advertisement Find a Broker - Visit the DailyFinance Broker Center

DJIA	12,454.83	-74.92	-0.60%
NASDAQ	2,837.53	-1.85	-0.07%
S&P 500	1,317.82	-2.86	-0.22%

Recent Quotes Watchlist My Portfolios

Add

$19.27 $0.17 (0.86%)

REAL-TIME: Last trade at 4:00 PM EDT on 05/25/12

Auxilium Pharmaceuticals, Inc.

NASDAQ:AUXL

+ Add to Portfolio
+ Add to Alerts

Related Resources

Auxilium Pharmaceuticals and FCB File Lawsuit Against Watson for Infringement of Testim Patents

5/24/2012 by Pharmaceutical Processing

Auxilium announces lawsuit against Watson for infringement of Testim patents

5/24/2012 by Theflyonthewall.com

Auxilium Pharmaceuticals, Inc. and FCB I LLC File Lawsuit Against Watson for Infringement of Testim® Patents

5/24/2012 by PR Newswire

Auxilium upgraded to Buy from Neutral at MKM Partners (pre-open)

5/22/2012 by Theflyonthewall.com

Canaccord Genuity maintains a 'Buy' on Auxilium Pharmaceuticals (AUXL); Bumping Guidance on Testim Partnership with GSK

5/22/2012 by StreetInsider.com

Auxilium lowers FY12 net loss to ($10M)-($5M) from ($15M)-($5M)

5/21/2012 by Theflyonthewall.com

Auxilium raises FY12 global Testim revenue to $225M-$235M from $215M-$225M

5/21/2012 by Theflyonthewall.com

Auxilium raises FY12 revenue to $293M-$315M from $283M-$305M

5/21/2012 by Theflyonthewall.com

Auxilium, GlaxoSmithKline enter co-promotion agreement for Testim

5/21/2012 by Theflyonthewall.com

Auxilium Pharmaceuticals, Inc. Raises Revenue Guidance And Reduces Net Loss Guidance For 2012

5/21/2012 by PR Newswire

A Forward Look, The Year Ahead - Featured Research on Auxilium Pharmaceuticals, Inc. and Prestige Brands Holdings, Inc.

5/17/2012 by Marketwire

Auxilium Pharmaceuticals, Inc. and FCB I LLC Announce the Issuance of Composition of Matter Patent Covering Testim

5/17/2012 by StockWatch

Auxilium announces issuance of composition of matter patent covering Testim

5/17/2012 by Theflyonthewall.com

Armando Anido Joins Respira Therapeutics, Inc. Board of Directors

5/16/2012 by PR Newswire

Auxilium shares undervalued, says Cowen at Cowen

5/14/2012 by Theflyonthewall.com

Auxilium management to meet with RBC Capital

5/11/2012 by Theflyonthewall.com

8 Stocks Ripping Higher on Big Volume

5/11/2012 by TheStreet.com

Canaccord Genuity Maintains a 'Buy' on Auxilium Pharmaceuticals (AUXL); Q1 Review; All Eyes on P3 Xiaflex Data

5/11/2012 by StreetInsider.com

Auxilium Pharmaceuticals, Inc. to Present At The BofAML 2012 Health Care Conference

5/11/2012 by StockWatch

Auxilium Pharmaceuticals, Inc. to Present At The BofAML 2012 Health Care Conference

5/11/2012 by PR Newswire

Auxilium Pharmaceuticals, Inc. (AUXL) Tops Q1 EPS by 8c

5/10/2012 by StreetInsider.com

Auxilium reports Q1 EPS (4c), consensus (12c)

5/10/2012 by Theflyonthewall.com

Auxilium Pharmaceuticals, Inc. Announces First Quarter 2012 Financial Results

5/10/2012 by PR Newswire

Auxilium announces Xiaflex Phase IIb study to be published

5/9/2012 by Theflyonthewall.com

Auxilium Pharmaceuticals, Inc. Announces XIAFLEX® Peyronie's Phase IIb Study Published In The Journal Of Urology

5/9/2012 by PR Newswire

Leerink's biotech analyst holds an analyst/industry conference call

4/24/2012 by Theflyonthewall.com

Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference

4/24/2012 by StockWatch

Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference

4/24/2012 by PR Newswire

Auxilium Pharmaceuticals, Inc. and FCB I LLC Receive Paragraph IV Certification Notice from Watson Laboratories, Inc. for Testim

4/16/2012 by Genetic Engineering News

Auxilium Pharmaceuticals, Inc. and FCB I LLC Receive Paragraph IV Certification Notice from Watson Laboratories, Inc. for Testim®

4/16/2012 by PR Newswire

Auxilium gets notice from Watson Labs on Testim

4/16/2012 by Theflyonthewall.com

Auxilium Pharmaceuticals Has The Approvals; Can It Get The Revenue?

3/28/2012 by Seeking Alpha

Canaccord Genuity Starts Auxilium Pharmaceuticals (AUXL) at Buy

3/26/2012 by StreetInsider.com

Auxilium Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

3/26/2012 by PR Newswire

Auxilium Pharmaceuticals to Present at the 2012 Barclays Capital Global Healthcare Conference

3/8/2012 by PR Newswire

Auxilium Pharmaceuticals to Present at the 2012 Cowen Healthcare Conference

2/27/2012 by PR Newswire

Deutsche Bank Raises Price Target on Auxilium Pharmaceuticals (AUXL) to $22 After Q4

2/24/2012 by StreetInsider.com

BioSpecifics Announces Partnership Between Auxilium and Actelion for XIAFLEX® in Canada, Australia, Brazil and Mexico

2/23/2012 by PR Newswire

Auxilium management to meet with RBC Capital

2/23/2012 by Theflyonthewall.com

Auxilium sees 2012 U.S. XIAFLEX net revenues $55M-$65M

2/23/2012 by Theflyonthewall.com

See More Articles...

Get the latest AUXL stock information on the web. Get the latest stock quote and more - DailyFinance is your source for Auxilium Pharmaceuticals, Inc. stock price.

BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
Analyst Recommendations provided by Midnight Trader, Inc. Company Conference Calls provided by Wall Street Horizon.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions.

Notices & Terms: Confirm all data with your broker before trading.

Questions or Comments? Please give feedback here.

© 2012 AOL Inc. All Rights Reserved.

AOL@Money © 2012 AOL Inc. All Rights Reserved.

WEB106 / 31.2512 ms